W.H. Cornerstone Investments Inc. Sells 331 Shares of UnitedHealth Group Incorporated $UNH

W.H. Cornerstone Investments Inc. cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.3% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 664 shares of the healthcare conglomerate’s stock after selling 331 shares during the quarter. W.H. Cornerstone Investments Inc.’s holdings in UnitedHealth Group were worth $207,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of UNH. Good Life Advisors LLC boosted its holdings in shares of UnitedHealth Group by 396.7% during the 2nd quarter. Good Life Advisors LLC now owns 4,883 shares of the healthcare conglomerate’s stock worth $1,524,000 after purchasing an additional 3,900 shares during the last quarter. ABN Amro Investment Solutions acquired a new stake in UnitedHealth Group during the second quarter worth approximately $10,362,000. Cherokee Insurance Co purchased a new stake in shares of UnitedHealth Group during the second quarter worth approximately $1,809,000. Police & Firemen s Retirement System of New Jersey boosted its holdings in UnitedHealth Group by 3.2% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 138,189 shares of the healthcare conglomerate’s stock worth $43,111,000 after buying an additional 4,254 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in UnitedHealth Group by 3.3% during the 2nd quarter. Geode Capital Management LLC now owns 21,312,182 shares of the healthcare conglomerate’s stock valued at $6,624,411,000 after buying an additional 675,075 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH traded down $2.49 during trading hours on Thursday, hitting $336.57. The stock had a trading volume of 2,128,485 shares, compared to its average volume of 12,239,969. The stock has a market capitalization of $304.88 billion, a price-to-earnings ratio of 17.56, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $622.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The company’s fifty day moving average is $347.08 and its two-hundred day moving average is $320.66.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the company earned $7.15 earnings per share. The business’s revenue for the quarter was up 12.2% on a year-over-year basis. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.6%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on UNH. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. Piper Sandler reduced their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Finally, Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.